Jay Bradner: I am overjoyed by the opportunity to create and develop therapeutic solutions for patients

Jay Bradner, Executive Vice President of R&D, and Chief Scientific Officer at Amgen shared on LinkedIn:

“Bob Bradway today announced that I have joined his leadership team as Executive Vice President of R&D, and Chief Scientific Officer. I am overjoyed by the opportunity to create and develop therapeutic solutions for patients with serious illnesses and to work alongside such wonderful people. Here are some additional reflections.”

For details click here.
Source: Jay Bradner/LinkedIn